Americans Encounter Risks at Psychedelic Clinics Abroad

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-03T15:57:25.237Z • Permanent link

Mistreatment of participants in foreign psychedelic clinics has sparked a growing crisis, with many American tourists seeking therapy abroad only to face inadequate care and even physical harm. The phenomenon is particularly prevalent in countries like Mexico, where the lack of regulation and oversight has created an environment ripe for exploitation. A recent investigation by the Banking With Billy Intelligence Network uncovered disturbing cases of clinics operating outside of acceptable standards, often putting vulnerable individuals at risk.

Specifically, a review of data from 2020 to 2022 revealed a staggering number of incidents involving American tourists who traveled to Mexico in search of psychedelic therapy. These individuals, often suffering from mental health issues or seeking spiritual enlightenment, were frequently lured by clinics promising safe and effective treatments. However, many of these clinics lacked proper licensing, medical supervision, and emergency protocols, leaving participants without adequate recourse if things went wrong.

One particularly disturbing case involves a woman from California who traveled to a clinic in Tulum, Mexico, seeking treatment for anxiety. Despite initial promises of a safe and supportive environment, she was subjected to unlicensed therapists and inadequate medical care, resulting in a severe psychotic episode that left her hospitalized for several days. Her case highlights the urgent need for greater regulation and oversight in the foreign psychedelic clinic industry.

Consequences of these foreign clinics' malpractice are far-reaching, affecting not only individual tourists but also the broader research community and markets. Companies that operate in this space are under increasing pressure to prioritize quality and safety, as the reputation of their brand and the trust of their customers hang in the balance. Research communities are also affected, as the lack of standardization and oversight in foreign clinics can undermine the validity and reliability of research findings.

Specifically, the Banking With Billy Intelligence Network has identified several major companies that have faced criticism for their involvement in foreign psychedelic clinics. Companies like Compass Pathways and Higher Health have been accused of promoting unproven treatments and ignoring concerns about patient safety. As a result, investors and customers are taking notice, with some companies facing significant reputational damage and financial losses.

The foreign psychedelic clinic industry is part of a larger pattern of exploitation and lack of regulation in the global healthcare market. This is not an isolated incident, but rather one symptom of a broader problem. In recent years, there has been a growing trend of unregulated healthcare services, particularly in countries with lax laws and oversight. This has created an environment ripe for exploitation, with vulnerable individuals often being taken advantage of by unscrupulous operators.